IVDD Compliance: Firms Encounter Authorized Rep, Risk Management Issues
This article was originally published in The Gray Sheet
Executive Summary
U.S. manufacturers preparing to comply with the European Union's In Vitro Diagnostics Directive (IVDD) by Dec. 7, 2003 should consider carefully the extent of control granted to authorized representatives in the EU, according to IVD stakeholders